HIV molecular immunology database
Found 1 matching record:
HXB2 Location | Pol(101-110) | Pol Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
KMIGGIGGFI
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | KI10 | ||||||||
Species (MHC/HLA) | human(A2, B62) |
Showing all: 2 variant(s).
Variant ID. | 1328 |
---|---|
Epitope Seq. | KMIGGIGGFI |
Variant Seq. | KiIGGIGGFI |
Mutations | M/I |
Epitope Location | M2I |
HXB2 Location | M102I |
Mutation Type | DI: drug induced E: escape documented in this paper SF: susceptible form |
Method | CD8 T-cell Elispot - IFNy, Sequence |
Note | PBMC from HLA-A2 and HLA-B62-positive patients were stimulated with the index peptide KMIGGIGGFI and the tipranavir and atazanavir induced variants KiIGGIGGFI and KMIGGIGGFv, and evaluated for cross recognition. In samples from some A2-positive patients CD8+-T-cell recognition was abolished by these mutations, whereas in samples from other A2-positive patients a CD8+-T-cell response was induced only by the mutant peptides. |
Variant ID. | 1329 |
---|---|
Epitope Seq. | KMIGGIGGFI |
Variant Seq. | KMIGGIGGFv |
Mutations | I/V |
Epitope Location | I10V |
HXB2 Location | I110V |
Mutation Type | DI: drug induced E: escape documented in this paper SF: susceptible form |
Method | CD8 T-cell Elispot - IFNy, Sequence |
Note | PBMC from HLA-A2 and HLA-B62-positive patients were stimulated with the index peptide KMIGGIGGFI and the tipranavir and atazanavir induced variants KiIGGIGGFI and KMIGGIGGFv, and evaluated for cross recognition. In samples from some A2-positive patients CD8+-T-cell recognition was abolished by these mutations, whereas in samples from other A2-positive patients a CD8+-T-cell response was induced only by the mutant peptides. |
Mueller2007 Sandra M. Mueller, Birgit Schaetz, Kathrin Eismann, Silke Bergmann, Michael Bauerle, Matthias Schmitt-Haendle, Hauke Walter, Barbara Schmidt, Klaus Korn, Heinrich Sticht, Bernd Spriewald, Ellen G. Harrer, and Thomas Harrer. Dual Selection Pressure by Drugs and HLA Class I-Restricted Immune Responses on Human Immunodeficiency Virus Type 1 Protease. J. Virol., 81(6):2887-2898, Mar 2007. PubMed ID: 17202219. Show all entries for this paper.